You searched for Parkinson's - Page 12 of 20

News and Trends 17 Nov 2016

UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy

…stage. Meanwhile, the programs focusing on Sanfilippo B and Parkinson’s will be left behind and possibly discontinued or licensed out. UniQure expects this move will save it up to €15M…

November 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 29 Nov 2016

New British Partnership set to Cure Rare Diseases with Gene Therapy

…also a big challenge. Oxford BioMedica seems like the perfect partner to ensure success: its versatile LentiVector platform is being used in clinical trials for Parkinson’s, several ocular diseases and…

November 29, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 May 2023

Pancreatic cancer microbiome discovery holds treatment hope

…neurological diseases such as Alzheimer’s disease and Parkinson’s disease. “Our bacteriophage-based new drug is undoubtedly a ‘first-in-concept’ drug that can effectively control various immune-related diseases. Therefore, we will continue to…

May 30, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

…in 2013 Katharine teamed up with the Medical Research Council UK to create sculptures of her own anatomy, including a life size glass heart, created from MRI scans. With Parkinson’s…

April 23, 2016 - 4 minutesmins - By Dani Bancroft

Best in Biotech 10 Jun 2025

Pushing biotech forward in France: 18 companies to know about

…neurodegenerative disorders like Alzheimer’s and Parkinson’s diseases. Cilcare is also conducting the SAPHIR observational study to explore the link between hearing impairments and neurodegenerative diseases. The study aims to develop…

June 10, 2025 - 16 minutesmins - By Jules Adam

More News! 10 Dec 2024

Biotech in 2024: A retrospective

…adults with advanced Parkinson’s disease, providing a new approach to managing this neurodegenerative disorder. Hympavzi – Pfizer: In October 2024, the FDA approved Hympavzi for treating adults and adolescents with…

December 10, 2024 - 14 minutesmins - By Jules Adam

News and Trends 22 Feb 2017

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

…is being tested in 3 Phase I trials to treat dementia (including Alzheimer’s and Parkinson’s), multiple sclerosis and Huntington’s. Minoryx Therapeutics is committed to finding innovative treatments for life-threatening…

February 22, 2017 - 5 minutesmins - By External Contributor

gene therapy cell therapy advanced therapy 4BIO

News and Trends 9 Sep 2019

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

…accelerate the development of gene therapies for more common diseases, such as Parkinson’s disease. “We have a great opportunity to buck the trend,” Kuzmin said to me. “For the past…

September 9, 2019 - 3 minutesmins - By Jonathan Smith

huntingtons disease gene therapy uniqure2 1

News and Trends 23 Jan 2019

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

…like Parkinson’s, so perhaps their technology could be transferred across. The use of gene therapy to correct a gene mutation that can have such devastating effects will be an effective…

January 23, 2019 - 3 minutesmins - By Alex Dale

News and Trends 17 May 2016

New Italian Drug is FDA approved for trials in Rare Neurological Disease

…Newron is a Biopharma developing therapies for diseases of the central nervous system (CNS). Last year it raised over €23M to advance its pipeline, which features candidates for Parkinson’s disease…

May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro

Weekly Roundup 15 Dec 2023

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

…that treat a range of neurological conditions like schizophrenia, Parkinson’s disease, and mood disorders, hence widening AbbVie’s existing neuroscience portfolio. This means that AbbVie will own the rights to Cerevel’s…

December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Jan 2017

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

…after. Although its platform for inhibitors of the deubiquitinating enzyme (DUB) it still in preclinical stage, Mission Therapeutic’s already has two candidates, USP30 and USP7, lined up to target Parkinson’s…

January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy

New British Partnership set to Cure Rare Diseases with Gene Therapy

Pancreatic cancer microbiome discovery holds treatment hope

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Pushing biotech forward in France: 18 companies to know about

Biotech in 2024: A retrospective

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

New Italian Drug is FDA approved for trials in Rare Neurological Disease

Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered

The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!